| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |